White Paper

Pharma & Biotech Capital Spending Trends: Navigating a Shift in Global Manufacturing

Please complete the form to receive the exclusive white paper.

Executive Summary

The global pharma and biotech sector is in the midst of a sustained capital spending cycle, driven by U.S. reshoring, tari pressures, and the structural shift toward outsourced manufacturing. Drawing on Industrial Info Resources' (IIR) database of 338,000+ operational plants, this white paper examines whether the industry is experiencing a temporary CapEx boom or a permanent realignment of where and how it manufactures.

Pharma & Biotech Capital Spending Trends: Navigating a Shift in Global Manufacturing

First Name *

First name is required.

Last Name *

Last name is required.

Email *

Please enter a valid email address.

Phone Number *

Please enter a valid phone number.

Include country code for international numbers (e.g. +44 20 7946 0000)

Company Name

Company name is required.

Job Title

Connect With Us

For more info

Industrial oil refinery and chemical plant illuminated at dusk with a field in the foreground